EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Contrast enhanced ultrasound evaluation of nephron sparing treatment for renal cell carcinoma

Richard G Barr, Davide Roccarina, Louis Mazzareilli, Parker Bauman, Kevin Cheng

Abdominal Radiology · 2025

DOI: 10.1007/s00261-025-05314-y ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Abdominal Radiology, 2025. Verfasst von Richard G Barr und 4 weiteren Autor:innen. Beteiligte Einrichtung: Northeast Ohio Medical University, Rootstown, USA. rgbarr525@gmail.com. Hauptthemen laut MEDLINE: Kidney Neoplasms, Carcinoma, Renal Cell, Contrast Media, Organ Sparing Treatments. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To determine the accuracy of CEUS in identifying residual or recurrent tumor post nephron-sparing procedures. Materials and methods CEUS studies performed post nephron sparing procedure (RFA, cryoablation, MWA, partial nephrectomy) from January 2018 to May 2025 were retrospectively reviewed at 2 centers. Informed consent was waived. Patient charts were reviewed for follow-up procedures and patient status. CEUS studies were performed on a Philips Epic ultrasound with a C5-1 transducer using Lumason with a dose of 1.0 to 2.0 cc. A 3-minute cine clip was saved. An examination was considered a true positive if there was contrast in the procedure site and either biopsy proven tumor or persistent enhancement for over 1 year. An examination was considered a true negative if there was no contrast enhancement in the procedure site.

Results

There were 193 lesions in 188 patients. (mean age 68.0 years +/− 1.4 {SD} (range 33–90) ; 115 men). There were 16 radiofrequency ablation, 38 cryoablations, 4 microwave ablations, and 135 partial nephrectomies. The average lesion size was 2.9 cm (IQR 2.2,3.7; range 1.4–7.1 cm). There were 17 (8.8%) true positive cases and 176 (91.2%) true negative cases. Time of follow-up ranged from 1 to 336 months (mean 35.1, IQR 12, 70). There were no false positive or false negative cases based on biopsy and long-term follow-up. There were 92 (47.7%) that also had CECT. There was 96.7% concordance of CEUS with CT. There were 3 CEUS cases positive with a negative CECT.

Conclusions

CEUS is an accurate method in determining residual or recurrent tumor in patients having nephron sparing procedures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney NeoplasmsCarcinoma, Renal CellContrast MediaOrgan Sparing TreatmentsImage EnhancementHumansMaleAgedUltrasonographyFemaleNephronsRetrospective StudiesMiddle AgedAged, 80 and overAdultNeoplasm Recurrence, LocalNephrectomy

Stichwörter der Autor:innen

CEUSMicrowave ablationPartial nephrectomyRadiofrequncy ablationRenal sparing proceduresTumor recurrence

Substanzen

Contrast Media

Autor:innen und Institutionen

  • Northeast Ohio Medical University, Rootstown, USA. rgbarr525@gmail.com.
  • Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
  • Yale New Haven Health System, New Haven, USA.
  • Northeast Ohio Medical University, Rootstown, USA.

Zitieren

APA

Barr, R. G., Roccarina, D., Mazzareilli, L., Bauman, P., & Cheng, K. (2025). Contrast enhanced ultrasound evaluation of nephron sparing treatment for renal cell carcinoma. Abdominal Radiology. https://doi.org/10.1007/s00261-025-05314-y

Vancouver

Barr RG, Roccarina D, Mazzareilli L, Bauman P, Cheng K. Contrast enhanced ultrasound evaluation of nephron sparing treatment for renal cell carcinoma. Abdominal Radiology. 2025. doi:10.1007/s00261-025-05314-y

BibTeX
@article{Barr2025,
  author = {Barr, Richard G and Roccarina, Davide and Mazzareilli, Louis and Bauman, Parker and Cheng, Kevin},
  title = {Contrast enhanced ultrasound evaluation of nephron sparing treatment for renal cell carcinoma},
  journal = {Abdominal Radiology},
  year = {2025},
  doi = {10.1007/s00261-025-05314-y}
}
Kostenlos starten →